Coherus Biosciences | CHRS - Eps Gewinn Pro Aktie

Aktienkurs
1.54
Täglich Wechseln
-0.08 -4.66%
Monatlich
-5.25%
Jährlich
49.03%
Q1 Prognose
1.58




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
Akebia Therapeutics USD -0.04 0.04 2025-12
ALKERMES USD 0.29 0.2 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Amarin USD 0.14 0.06 2025-12
Amgen USD 5.29 0.35 2025-12
Baxter International USD 0.44 0.25 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Fujifilm JPY 60.69 5.53 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Ironwood Pharmaceuticals USD -0.01 0.25 2025-12
Merck USD 2.04 0.54 2025-12
Myriad Genetics USD 0.04 0.33 2025-12
Pacira USD 0.06 0.64 2025-12
Perrigo USD 0.77 0.03 2025-12
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Teva Pharmaceutical Industries USD 2.98 0.43 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12
Xencor USD -0.09 0.01 2025-12
Zoetis USD 1.48 0.22 2025-12